Fixed And Mobile C-arms Market Size, Share & Trends Analysis Report By Product (Fixed C-arms, Mobile C-arms), By Application (Neurosurgery, Cardiovascular), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Fixed And Mobile C-arms Market Size, Share & Trends Analysis Report By Product (Fixed C-arms, Mobile C-arms), By Application (Neurosurgery, Cardiovascular), By End Use, By Region, And Segment Forecasts, 2025 - 2030


Irradiation Apparatus Market Growth & Trends

The global irradiation apparatus market size is estimated to reach USD 11.14 billion in 2030 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. Irradiation apparatus produces radiation in the form of high-speed neutrons, gamma rays, X-rays, electrons, and alpha–beta particles. Food and Drug Administration (FDA) through the Food and Drug Administration Modernization Act (FDAMA) recognizes various X-ray imaging standards. The combination of laser beam along with rotary laser irradiation apparatus enables uniform width irradiation, a phenomenon called linear welding. Using conventional irradiation apparatus was expensive and inconvenient, and at the same time portable irradiation apparatus made a breakthrough by working on these restraints. X-ray has its applications in metal detection, securing against terrorist attacks, and body scanners; while advances such as linear accelerators and accelerator electrons have made their mark in medical and research industries, medical, veterinary, research purposes, dental, and podiatric diagnosis.

Irradiation Apparatus Market Report Highlights
  • X-Rays segment held the largest market share of about 33.65% in 2024. The segment growth is driven by increasing healthcare demands, particularly for diagnostic imaging services due to the rising prevalence of chronic diseases such as cancer and cardiovascular conditions
  • Gamma rays segment is expected to grow at the fastest rate of 7.2% CAGR over the forecast period, owing to the factors such as gamma irradiation is cost-effective, safe, and is widely used in oncology for radiotherapy and in sterilizing medical devices
  • Diagnostics segment held the largest market share of about 41.31% in 2024
  • Hospitals segment held the largest market share of about 44.7% in 2024, as hospitals are investing heavily in upgrading their medical imaging capabilities to enhance patient outcomes and operational efficiency, thereby driving growth in this segment
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Fixed and Mobile C-arms Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing number of surgical procedures
3.2.1.2. Technological advancements
3.2.1.3. Increasing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. High cost of C-arm system
3.2.2.2. Complex regulatory environment
3.3. Fixed and Mobile C-arms Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Fixed and Mobile C-arms Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Fixed and Mobile C-arms Product Market Movement Analysis
4.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Fixed C-arms
4.4.1. Fixed C-arms market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Mobile C-arms
4.5.1. Mobile C-arms market estimates and forecasts 2018 - 2030 (USD Million)
4.5.1.1. Full size C-arms
4.5.1.1.1. Full size C-arms market estimates and forecasts 2018 - 2030 (USD Million)
4.5.1.2. Mini C-arms
4.5.1.2.1. Mini C-arms market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. Fixed and Mobile C-arms Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Fixed and Mobile C-arms Application Market Movement Analysis
5.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Orthopedics and Trauma
5.4.1. Orthopedics and trauma market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Neurosurgery
5.5.1. Neurosurgery market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Cardiovascular
5.6.1. Cardiovascular market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Pain Management
5.7.1. Pain management market estimates and forecasts 2018 - 2030 (USD Million)
5.8. Gastroenterology
5.8.1. Gastroenterology market estimates and forecasts 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Fixed and Mobile C-arms Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Fixed and Mobile C-arms End Use Market Movement Analysis
6.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Research Institutions
6.6.1. Research institutions market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Fixed and Mobile C-arms Market: Regional Estimates & Trend Analysis By Product, Application, End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 - 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. GE HealthCare
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Koninklijke Philips N.V.
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers AG
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Medtronic
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Shimadzu Corporation
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Hologic, Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Canon Medical Systems Corporation
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Fujifilm Holdings Corporation
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Ziehm Imaging GmbH
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings